Study Of Perennial Allergic Rhinitis

Study of Perennial Allergic Rhinitis -Long Term Treatment Study-

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00358475

Enrollment

Registered

2006-07-31

Start date

2005-06-21

Completion date

2005-10-12

Last updated

2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinitis, Allergic, Seasonal

Keywords

perennial allergic rhinitis

Brief summary

This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.

Interventions

DRUGGW685698

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

* Informed consent. * Outpatient. * Diagnosis of perennial allergic rhinitis with symptoms. * Able to comply with study procedures.

Exclusion criteria

* Significant concomitant medical condition. * Use of corticosteroids/allergy medications. * Laboratory abnormality. * Positive pregnancy test.

Design outcomes

Primary

Measure	Time frame
Adverse events and laboratory blood test	—

Secondary

Measure	Time frame
Change of nasal symptom score	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026